Diabetes affects millions worldwide, and while it's primarily known for disrupting blood sugar regulation, its impact extends ...

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Diabetic retinopathy screening with AI was associated with higher referral rates to optical coherence tomography but remains underutilized.

The global prevalence of diabetes continues to rise, projected to impact 700 million individuals by 2045. This increase parallels a significant growth in diabetes-associated complications, with ...

Vision is one of the most important aspects of daily life, and taking care of your eyes is an essential part of managing ...

Nonprofit healthcare system UMass Memorial Health (UMMH) has integrated AEYE Health's AI-based AEYE-DS autonomous diagnostic ...

Ahead of this year's Floretina meeting and International Congress on OCT Angiography, En Face OCT and Advances in OCT (ICOOR), David Hutton of Ophthalmology Times spoke with Charles Wykoff, MD, PhD.

About AEYE Health: AEYE Health is a healthcare technology leader specializing in AI-powered retinal diagnostics. The ...